Patents by Inventor Maxime GUEGUINOU

Maxime GUEGUINOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ion channel inhibitor compounds for cancer treatment
    Patent number: 11932638
    Abstract: The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R? is an -A1-Cy1 group, or R is an -A1-Cy1 group and R? is an R1 group, R1 particularly being H or (C1-C6)alkyl group; A1 being an —NH— radical or —NH—CH2— radical; Cy1 particularly being a phenyl group, A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: March 19, 2024
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFQUE, UNIVERSITE D'ORLEANS, UNIVERSITE DE TOURS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE SCIENTIFIQUE (INSERM), CHU NANTES
    Inventors: Sylvain Routier, Frédéric Buron, Nuno Rodrigues, Gaëlle Fourriere-Grandclaude, Christophe Vandier, Aurélie Chantome, Marie Potier-Cartereau, Maxime Gueguinou, Séverine Marionneau-Lambot
  • ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT
    Publication number: 20210009581
    Abstract: The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R? is an -A1-Cy1 group, or R is an -A1-Cy1 group and R? is an R1 group, R1 particularly being H or (C1-C6)alkyl group; A1 being an —NH— radical or —NH—CH2— radical; Cy1 particularly being a phenyl group, A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.
    Type: Application
    Filed: May 23, 2018
    Publication date: January 14, 2021
    Inventors: Sylvain ROUTIER, Frédéric BURON, Nuno RODRIGUES, Gaëlle FOURRIERE-GRANDCLAUDE, Christophe VANDIER, Aurélie CHANTOME, Marie POTIER-CARTEREAU, Maxime GUEGUINOU, Séverine MARIONNEAU-LAMBOT